Skip to main content
. 2022 Feb 21;9:829117. doi: 10.3389/fcvm.2022.829117

Table 4.

Quantitative coronary angiography of treated lesions in the overall population and patient subgroups.

Overall Primary IVL Secondary IVL Bailout IVL ISR IVL p
No. of IVL treated lesions 110 25 51 11 23
Reference vessel
Diameter (mean ± SD), mm 3.26 ± 0.63 3.58 ± 0.6 3.22 ± 0.64 3.04 ± 0.47 3.13 ± 0.63 0.03
No. of lesions with RVD >3 mm, n (%) 70 (63.6) 20 (80) 30 (58.8) 7 (63.6) 13 (56.5) 0.27
Lesion—basal assessment
Length (mean ± SD), mm 20.46 ± 15.99 26.21 ± 22.29 18.96 ± 12.64 24.65 ± 18.22 15.54 ± 11.56 0.08
No. of long lesions, *n (%) 56 (50.9) 13 (52) 26 (51) 8 (72.7) 9 (39.1) 0.34
MLD (mean ± SD), mm 0.98 ± 0.46 1.07 ± 0.51 0.97 ± 0.4 0.84 ± 0.39 0.96 ± 0.56 0.56
DS (mean ± SD), % 70.1 ± 12.39 70.36 ± 12.84 69.33 ± 11.75 73.18 ± 10.30 70.04 ± 14.56 0.83
Lesion—final assessment
MLD (mean ± SD), mm 2.77 ± 0.62 3.08 ± 0.53 2.72 ± 0.65 2.50 ± 0.64 2.69 ± 0.57 0.03
DS (mean ± SD), % 14.94 ± 11.2 13.8 ± 5.53 15.27 ± 13.35 17.64 ± 16.8 14.13 ± 7 0.79
Acute Gain, mm 1.79 ± 0.6 2.01 ± 0.55 1.74 ± 0.64 1.66 ± 0.52 1.73 ± 0.60 0.23

Values are mean ± SD, n (%).

DS, diameter stenosis; ISR, in-stent restenosis; IVL, intravascular lithotripsy; MLD, minimal lumen diameter.

*

Defined as lesion length > 15 mm.